CCDC69 is expected to be an effective biomarker to predict the survival of breast cancer patients, facilitating the early diagnosis based on molecular subtypes, histological subtypes as well as lymph nodes metastasis of breast cancer. This evidence concerns the gene CCDC69 and breast carcinoma.